or
forgot password

    • cancer clinical trials in bristol, TN

    • Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Breast Neoplasms
    A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Advanced Solid Tumors
    Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Ewing's Sarcoma Family of Tumors
    Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Hematologic Neoplasms
    Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung
    Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Colorectal Neoplasms, Neoplasms
    A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Non-Small-Cell Lung Carcinoma, Adenocarcinoma
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 093
    Bristol, Tennessee 37620
    Hypoactive Sexual Desire Disorder
    A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Solid Tumors, Breast Cancer, Neoplasms
    Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Head and Neck Neoplasm, Prostatic Neoplasm, Pancreatic Neoplasm
    Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Adenosquamous Cell
    Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Carcinoma, Hepatocellular
    Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Advanced Solid Tumors, Non Small Cell Lung Cancer
    A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Cancer
    Rollover Protocol for Prior SU011248 Protocols
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Solid Tumors
    A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
    Pfizer Investigational Site
    Bristol, Tennessee 37620
    Advanced Non-Hematologic Malignancies
    An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
    Blue Ridge Medical Specialist
    Bristol, Tennessee 37620
    Chemotherapy-Induced Nausea and Vomiting